(Q41199457)

28 September 2017

1 reference

title

The clinical safety of H1-receptor antagonists. An EAACI position paper (English)

1 reference

28 September 2017

1 reference

Passalacqua G

1

1 reference

28 September 2017

Bousquet J

2

1 reference

28 September 2017

Bachert C

3

1 reference

28 September 2017

Church MK

4

1 reference

28 September 2017

Bindsley-Jensen C

5

1 reference

28 September 2017

Nagy L

6

1 reference

28 September 2017

Szemere P

7

1 reference

28 September 2017

Davies RJ

8

1 reference

28 September 2017

Durham SR

9

1 reference

28 September 2017

Horak F

10

1 reference

28 September 2017

Kontou-Fili K

11

1 reference

28 September 2017

Malling HJ

12

1 reference

28 September 2017

van Cauwenberge P

13

1 reference

28 September 2017

Canonica GW

14

1 reference

28 September 2017

publication date

1 October 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

51

1 reference

28 September 2017

issue

10

1 reference

28 September 2017

page(s)

666-675

1 reference

The physiological action of beta-iminazolylethylamine

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Definition and antagonism of histamine H 2 -receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Highly potent and selective ligands for histamine H3-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Histaminergic systems and sleep. Studies in man with H1 and H2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Driving performance under the influence of drugs: rationale for, and application of, a new test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

The effects of terfenadine with and without alcohol on an aspect of car driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Some clinical pharmacological studies with terfenadine, a new antihistamine drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Studies on the central effects of the H1-antagonist, loratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Histamine and cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Torsade de pointes induced by astemizole in a patient with prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Loratadine and ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

Hypertension during reduction of long-term steroid therapy in young subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

The pharmacology and use of H1-receptor-antagonist drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1996.TB02109.X

10.1111/J.1398-9995.1996.TB02109.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference